Brian Golden

Brian Golden, MS, PhD, FCAHS
Sandra Rotman Chaired Professor of Health Sector Strategy
Professor of Strategic Management
Academic Director, Sandra Rotman Centre for Health Sector Strategy
The Rotman School of Management & Faculty of Public Health
The University of Toronto
T: 416-946-8519
bgolden@rotman.utoronto.ca

Professor Brian Golden (PhD, Kellogg School of Management, Northwestern University) is the Sandra Rotman Chaired Professor in Health Sector Strategy at the Rotman School of Management, The University of Toronto.  He is  Academic Director of Rotman’s Global Executive MBA and Rotman’s Global Executive MBA in Healthcare and The Life Sciences.  He previously served as Vice-Dean Professional Programs and Vice-Dean MBA Programs.

Professor Golden was a member of the advisory committee that led to the creation of Ontario’s Excellent Care for All legislation.  In 2013 he co-authored the province’s report on Primary Care Governance, and in 2015 co-authored “Patient Care Groups:  A new model of population based primary health care for Ontario” (the “Price Report”) for the Ministry of Health.  Professor Golden was Board Chair of the Institute for Clinical Evaluative Sciences (ICES). 
 
Professor Golden conducts research, teaches and consults in the areas of change management, leadership, incentives and payment models, system design and governance.  Among his published work are articles in The Harvard Business Review, The Canadian Medical Association Journal, The Strategic Management Journal, Healthcare Quarterly, Healthcare Papers, The Annals of Pharmacotherapy, Management Science, Clinical Oncology, and Health Policy. Professor Golden’s article “Transforming Healthcare Organizations” in Healthcare Quarterly has been that publication’s most downloaded article with over 200,000 downloads.
 
As an advisor and director of leadership development programs, Professor Golden has worked with a variety of organizations including Ontario’s Ministry of Health, several Medical Associations in Canada, Britain’s National Health Service, health regions across Canada, and hospitals including The Hospital for Sick Children, The University Health Network, Hamilton Health Sciences, London Health Science Centre, Sunnybrook College Health Sciences Centre, The Centre for Addiction and Mental Health, British Columbia Cancer Agency, The King Faisal Specialist Hospital, and Baylor Medical Center. Private sector clients include Tieto (Finland), General Electric, Janssen-Ortho, Philips and Baxter. 
 
His honours include Canada’s Ted Freedman Innovation in Healthcare Education Award and the Canadian Medical Association’s first Eureka Award for Innovation in Physician Education.  In 2016 he was made a Fellow of the Canadian Academy of Health Sciences.

Kate Hanneman, MD, MPH, FRCPC

Dr. Hanneman is an Associate Professor at the University of Toronto and a Clinician Scientist at the Toronto General Hospital Research Institute. She is the Director of Cardiac Imaging Research at the Joint Department of Medical Imaging and the Medical Imaging Site Director at Women’s College Hospital. Dr. Hanneman is an Associate Editor and Chair of the Radiology: Cardiothoracic Imaging Trainee Editorial Board. She has received grant funding as principal investigator from the Canadian Institute of Health Research and leads an active research program focused on improving health outcomes for patients with cardiomyopathies using cardiac imaging.

Adam Gehring, PhD

Dr. Gehring is the Biology Lead and Senior Scientist at the Toronto Center for Liver Disease and Associate Professor in the Department of Immunology at the University of Toronto. He runs a translational, human HBV immunology research lab focused on liver pathogenesis and sex-based differences in disease progression. His primary interest lies in defining the mechanisms driving liver inflammation during HBV-related flares using functional and transcriptomic approaches in liver biopsies. He also runs an immune monitoring lab for the Toronto Centre for Liver Disease to process and analyze immune responses in Phase 1/2 clinical studies for novel therapeutic agents targeting HBV. 

Heather Reich, MD CM, PhD, FRCP(C)  

Dr. Reich is the Oreopoulos-Baxter Division Director of Nephrology at the Department of Medicine of University of Toronto.  She is a clinician-scientist and holds the Gabor Zellerman Chair in Nephrology Research. Dr. Reich directs the glomerulonephritis program at Toronto General Hospital.  This program spans clinical care of patients with glomerulonephritis, contribution to innovative clinical trials and translational research.  She has previously served as the co-director of the annual educational pre-course in glomerulonephritis for the American Society of Nephrology, and contributed to the 2021 ISN-KDIGO guidelines for the treatment of glomerulonephritis.  

Kathryn Howe, MD, PhD, FRCSC 

Kathryn completed her PhD at McMaster University in the Molecular Immunology, Virology and Inflammation program. Kathryn went to medical school at the University of Toronto and completed a post-doctoral fellowship at Sick Kids, publishing in several fields during this time, including infection and immunity in HIV, ethics and sustainability in global surgery, and ischemia-reperfusion. She has been awarded competitive Canadian Institutes of Health Research (CIHR) Fellowships and National scholarships throughout her research training. As part of her Vascular Surgery residency, Kathryn completed a 3-month clinical and research fellowship at Stanford University. Kathryn is the first female Surgeon-Scientist in Vascular Surgery in Toronto, establishing her own laboratory investigating the role of endothelial communication in vascular disease in 2018. Her clinical initiative is carotid revascularization and stroke prevention, which dovetails with her bench research program. She collaborates extensively with Dr. Jason Fish. Kathryn’s CIHR-funded research program is looking at the role of endothelial activation/inflammation in carotid atherosclerosis and uses cell culture and animal models, as well as human tissue from the Peter Munk Cardiac Centre Biobank. Additional projects include endothelial regulation of immune cell function, endothelial senescence, and endothelial identity. In collaboration with the PMCC Artificial Intelligence group, she is trying to identify the vulnerable carotid plaque through machine learning. Kathryn’s ultimate goal is to find regulators of atherosclerosis for development of innovative strategies to improve prevention and treatment in advance of devastating clinical events such as stroke.

Andrew Sage, PhD

Dr. Sage is an Assistant Scientist with the Toronto Lung Transplant Program at the Toronto General Hospital Research Institute and an Assistant Professor at the University of Toronto in Ontario, Canada. His research is focused on identifying and translating novel biomarkers and medical devices to aid in surgical decision-making during lung transplantation. He has a keen interest in cutting-edge technologies such as machine learning and artificial intelligence as well as remote piloted aircrafts. In 2021 Dr. Sage was part of the team that completed the world's first delivery of a human lung for transplant via drone in downtown Toronto. Prior to joining the Toronto Lung Transplant Program, Dr. Sage completed a PhD at the University of Toronto in Pharmaceutical Sciences and an MSc and BSc in Biochemistry at McMaster University and Queen's University. 

Golnaz Karoubi, PhD

Dr. Golnaz Karoubi is Assistant Scientist at the Toronto General Hospital Research Institute and principal investigator in the Latner Thoracic Research Labs. She currently holds an Assistant Professor appointment in the department of Laboratory Medicine and Pathobiology and a cross-appointment in the department of Mechanical and Industrial Engineering at the University of Toronto. Dr. Karoubi received her PhD in Applied Science and Engineering at the University of Toronto and joined the Lung Regenerative Medicine Program in the Department of Clinical Research in Berne University, Switzerland for a post-doctoral research fellowship. She stayed on as a Group Leader in 2008 to direct the basic and transitional science as related to Cancer Stem Cell and Lung Regenerative Medicine in the Department of Biomedical Research at the University of Berne until 2012.  In early 2012, she joined the team of Dr. Tom Waddell at the Toronto General Hospital Research Institute as a Senior Scientific Associate and was appointed to Assistant Scientist at the Toronto General Hospital Research Institute (University Health Network) in November 2019 and to Assistant Professor in the Department of Laboratory Medicine and Pathobiology in July 2020. She is the recipient of the Di Poce Research Scholar Award for Women in Transplantation. Her research interests include development of practical approaches for treatment of lung and airway disease. Studies focus on: (1) Lung, tracheal and airway regeneration; (2) Use of pluripotent derived airway epithelial cells for tissue engineering applications; and (3) cell-based therapeutic approaches for end-stage lung disease. 
 

TGHRI Research Day Agenda- FINAL.pdf

E-Poster submission is now closed